Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma

…, D Bechet, D Faury, N De Jay, LA Ramkissoon… - Nature …, 2014 - nature.com
Pediatric midline high-grade astrocytomas (mHGAs) are incurable with few treatment targets
identified. Most tumors harbor mutations encoding p.Lys27Met in histone H3 variants. In 40 …

Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging

…, B Xiao, J Cryan, S Ramkissoon, L Ramkissoon… - Clinical Cancer …, 2018 - AACR
Purpose: Isocitrate dehydrogenase (IDH) mutations in glioma patients confer longer survival
and may guide treatment decision making. We aimed to predict the IDH status of gliomas …

MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism

P Bandopadhayay, LA Ramkissoon, P Jain… - Nature …, 2016 - nature.com
Angiocentric gliomas are pediatric low-grade gliomas (PLGGs) without known recurrent
genetic drivers. We performed genomic analysis of new and published data from 249 PLGGs, …

Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1

LA Ramkissoon, PM Horowitz… - Proceedings of the …, 2013 - National Acad Sciences
Pediatric low-grade gliomas (PLGGs) are among the most common solid tumors in children
but, apart from BRAF kinase mutations or duplications in specific subclasses, few genetic …

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain …

J Ni, SH Ramkissoon, S Xie, S Goel, DG Stover… - Nature medicine, 2016 - nature.com
Brain metastases represent the greatest clinical challenge in treating HER2-positive breast
cancer. We report the development of orthotopic patient-derived xenografts (PDXs) of HER2-…

A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas

…, SH Ramkissoon, LA Ramkissoon… - Neuro …, 2017 - academic.oup.com
Background. Activating mutations or structural rearrangements in BRAF are identified in
roughly 75% of all pediatric low-grade astrocytomas (PLGAs). However, first-generation RAF …

Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors

SH Ramkissoon, P Bandopadhayay, J Hwang… - Neuro …, 2017 - academic.oup.com
Background. Clinical genomics platforms are needed to identify targetable alterations, but
implementation of these technologies and best practices in routine clinical pediatric oncology …

[PDF][PDF] Genomic sequencing for newborn screening: results of the NC NEXUS project

…, DM DeCristo, NT Strande, L Ramkissoon… - The American Journal of …, 2020 - cell.com
Newborn screening (NBS) was established as a public health program in the 1960s and is
crucial for facilitating detection of certain medical conditions in which early intervention can …

Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma

AL Green, SH Ramkissoon, D McCauley… - Neuro …, 2015 - academic.oup.com
Background Glioblastoma (GBM) is poorly responsive to current chemotherapy. The nuclear
transporter exportin 1 (XPO1, CRM1) is often highly expressed in GBM, which may portend …

Pediatric low-grade gliomas: how modern biology reshapes the clinical field

…, P Bandopadhayay, WL Bi, L Ramkissoon… - … et Biophysica Acta (BBA …, 2014 - Elsevier
Low-grade gliomas represent the most frequent brain tumors arising during childhood. They
are characterized by a broad and heterogeneous group of tumors that are currently …